The comparison of sensitivity and specificity of ELISA-based microneutralization test with hemagglutination inhibition test to evaluate neutralizing antibody against influenza virus (H1N1)

Iranian Journal of Public Health

Volumn 46, Issue 12, 2017, Pages 1690-1696

  Tavakoli, Ahmad ^a   Rezaei, Farhad ^a   Fatemi Nasab, Gazal Sadat ^a   Adja Minezhad Fard, Fatemeh ^a   Noroozbabaei, Zahra ^a   Mokhtari Azad, Talat ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hemagglutination inhibition assay; Influenza virus; Microneutralization assay; MicroNT ELISA; Serologi cal assays

Indexed keywords

EID: 85036525657     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Katz JM, Hancock K, Xu X (2011). Serologic as-says for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther, 9 (6): 669-83.
2. Playford EG, Dwyer DE (2002). Laboratory diag-nosis of influenza virus infection. Pathology, 34 (2): 115-25.
3. Li ZN, Lin SC, Carney PJ, et al (2014). IgM, IgG, and IgA antibody responses to influenza A (H1N1) pdm09 hemagglutinin in infected per-sons during the first wave of the 2009 pandemic in the United States. Clin Vaccine Immunol, 21 (8): 1054-60.
4. Trombetta CM, Montomoli E (2016). Influenza immunology evaluation and correlates of pro-tection: a focus on vaccines. Expert Rev Vaccines, 15 (8): 967-76.
5. Hirst GK (1941). The Agglutination of Red Cells by Allantoic Fluid of Chick Embryos Infected with Influenza Virus. Science, 94 (2427): 22-3.
6. Morokutti A, Redlberger-Fritz M, Nakowitsch S, et al (2013). Validation of the modified hemagglu-tination inhibition assay (mHAI), a robust and sensitive serological test for analysis of influenza virus-specific immune response. J Clin Virol, 56 (4): 323-30.
7. Allwinn R, Preiser W, Rabenau H, et al (2002). La-boratory diagnosis of influenza--virology or se-rology? Med Microbiol Immunol, 191 (3-4): 157-60.
8. Petric M, Comanor L, Petti CA (2006). Role of the laboratory in diagnosis of influenza during sea-sonal epidemics and potential pandemics. J Infect Dis, 194 Suppl 2:S98-110.
9. Rothbarth PH, Groen J, Bohnen AM, et al (1999). Influenza virus serology--a comparative study. J Virol Methods, 78 (1-2): 163-9.
10. Beyer WE, Palache AM, Luchters G, et al (2004). Seroprotection rate, mean fold increase, sero-conversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res, 103 (1-2): 125-32.
11. Zakay-Rones Z (2010). Human influenza vaccines and assessment of immunogenicity. Expert Rev Vaccines, 9 (12): 1423-39.
12. Ndifon W, Dushoff J, Levin SA (2009). On the use of hemagglutination-inhibition for influenza surveillance: surveillance data are predictive of influenza vaccine effectiveness. Vaccine, 27 (18): 2447-52.
13. Stephenson I, Wood J, Nicholson K, et al (2004). Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res, 103 (1): 91-5.
14. Stephenson I, Wood JM, Nicholson KG, et al (2003). Sialic acid receptor specificity on eryth-rocytes affects detection of antibody to avian in-fluenza haemagglutinin. J Med Virol, 70 (3): 391-8.
15. Subbarao EK, Kawaoka Y, Ryan-Poirier K, et al (1992). Comparison of different approaches to measuring influenza A virus-specific hemagglu-tination inhibition antibodies in the presence of serum inhibitors. J Clin Microbiol, 30 (4): 996-9.
16. Sui J, Hwang WC, Perez S, et al (2009). Structural and functional bases for broad-spectrum neu-tralization of avian and human influenza A vi-ruses. Nat Struct Mol Biol, 16 (3): 265-73.
17. Rowe T, Abernathy RA, Hu-Primmer J, et al (1999). Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol, 37 (4): 937-43.
18. Gross P, Davis A (1979). Neutralization test in in-fluenza: use in individuals without hemaggluti-nation inhibition antibody. J Clin Microbiol, 10 (3): 382-4.
19. World Health Organization, Global influenza sur-veillance network (2011). Manual for the laboratory diagnosis and virological surveillance of influenza. World Health Organization, Geneva, Switzerland, pp: 63-77.
20. Kitikoon P, Vincent AL (2014). Microneutraliza-tion assay for swine influenza virus in swine se-rum. Methods Mol Biol, 1161: 325-35.
21. Moghadami M, Moattari A, Tabatabaee HR, et al (2010). High titers of hemagglutination inhibi-tion antibodies against 2009 H1N1 influenza vi-rus in Southern Iran. Iran J Immunol, 7 (1): 39-48.
22. Reed LJ, Muench H (1938). A simple method of estimating fifty per cent endpoints. Am J Epi-demiol, 27 (3): 493-7.
23. Vemula SV, Zhao J, Liu J, et al (2016). Current Ap-proaches for Diagnosis of Influenza Virus In-fections in Humans. Viruses, 8 (4): 96.
24. Laurie KL, Engelhardt OG, Wood J, et al (2015). International Laboratory Comparison of Influ-enza Microneutralization Assays for A (H1N1) pdm09, A (H3N2), and A (H5N1) Influenza Viruses by CONSISE. Clin Vaccine Immunol, 22 (8): 957-64.
25. Tremblay CL, Rouleau D, Fortin C, et al (2011). Immunogenicity and tolerability of an inactivat-ed and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients. Vaccine, 29 (7): 1359-63.
26. Stephenson I, Das RG, Wood JM, et al (2007). Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 vi-ruses: an international collaborative study. Vac-cine, 25 (20): 4056-63.
27. Stephenson I, Heath A, Major D, et al (2009). Re-producibility of serologic assays for influenza vi-rus A (H5N1). Emerg Infect Dis, 15 (8): 1252-9.
28. Hinshaw VS, Webster RG, Easterday BC, et al (1981). Replication of avian influenza A viruses in mammals. Infect Immun, 34 (2): 354-61.
29. Profeta ML, Palladino G (1986). Serological evi-dence of human infections with avian influenza viruses. Brief report. Arch Virol, 90 (3-4): 355-60.
30. Cheng LW, Huang SW, Huang LM, et al (2012). Comparison of neutralizing and hemagglutina-tion-inhibiting antibody responses for evaluating the seasonal influenza vaccine. J Virol Methods, 182 (1-2): 43-9.
31. Heckler R, Baillot A, Engelmann H, et al (2007). Cross-protection against homologous drift vari-ants of influenza A and B after vaccination with split vaccine. Intervirology, 50 (1): 58-62.
32. Lavenu A, Valleron A-J, Carrat F (2004). Exploring cross-protection between influenza strains by an epidemiological model. Virus Res, 103 (1): 101-5.
33. Skowronski DM, De Serres G, Janjua NZ, et al (2012). Cross-reactive antibody to swine influ-enza A (H3N2) subtype virus in children and adults before and after immunisation with 2010/11 trivalent inactivated influenza vaccine in Canada, August to November 2010. Euro Surveill, 17 (4): pii=20066.
34. Mandelboim M, Bromberg M, Sherbany H, et al (2014). Significant cross reactive antibodies to influenza virus in adults and children during a period of marked antigenic drift. BMC Infect Dis, 14: 346.
35. Medeiros R, Escriou N, Naffakh N, et al (2001). Hemagglutinin residues of recent human A (H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytes. Vi-rology, 289 (1): 74-85.